SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $10,441,000 | +6.0% | 697,201 | -13.8% | 0.00% | 0.0% |
| Q1 2016 | $9,849,000 | -11.1% | 808,966 | +16.2% | 0.00% | 0.0% |
| Q4 2015 | $11,079,000 | -45.7% | 696,322 | -47.7% | 0.00% | -50.0% |
| Q3 2015 | $20,390,000 | -28.1% | 1,330,231 | +14.4% | 0.00% | -33.3% |
| Q2 2015 | $28,344,000 | +15.4% | 1,162,793 | +10.1% | 0.00% | 0.0% |
| Q1 2015 | $24,558,000 | +4.6% | 1,056,227 | +13.0% | 0.00% | +50.0% |
| Q4 2014 | $23,485,000 | +1.3% | 935,107 | +25.4% | 0.00% | 0.0% |
| Q3 2014 | $23,187,000 | +18.2% | 745,500 | -1.8% | 0.00% | 0.0% |
| Q2 2014 | $19,622,000 | +11.4% | 758,783 | +0.7% | 0.00% | 0.0% |
| Q1 2014 | $17,617,000 | +81.3% | 753,677 | +73.4% | 0.00% | +100.0% |
| Q4 2013 | $9,716,000 | +94.8% | 434,713 | +77.7% | 0.00% | 0.0% |
| Q3 2013 | $4,987,000 | +43.3% | 244,599 | +47.4% | 0.00% | – |
| Q2 2013 | $3,481,000 | – | 165,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |